Delivery Order SPE2DB20D1100-SPE2DB25FE6L5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a competitive award with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of VENCLEXTA 100 mg tablets (120 count), valued at $9,728.17. This firm fixed-price, competitively awarded delivery order is expected to be completed by August 14, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) under a firm fixed-price contract. The order is scheduled for completion by September 11, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This is an unset-aside, competitively awarded contract that reflects the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a ceiling value of $9,728.17. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $9.73K delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Venclexta 100 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance to be completed by October 3, 2025, and fulfillment occurring at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a contract ceiling value of $19,456.34. This delivery order was issued under a firm fixed price arrangement with no set-aside designation, indicating competitive award. The ultimate completion date is set for September 30, 2025. As a child contract action, this delivery order derives from AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,579.40 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (28-count units) on September 12, 2025. This firm fixed-price, non-set-aside delivery order is scheduled for completion by October 3, 2025, with performance taking place at the contractor's Conshohocken, Pennsylvania location. The award represents a routine pharmaceutical procurement supporting federal medical supply chain requirements,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Venclexta 50 mg tablet unit dose packages (quantity 7). This non-set-aside, competitively awarded contract is valued at $1,743.06 with a firm fixed price and is scheduled for completion by September 4, 2025. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6L5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a ceiling value of $9,728.17. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical distributors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling AmerisourceBergen to supply a broad range of pharmaceutical products, specialty medications, and medical supplies to support military healthcare programs and Defense Health Agency operations worldwide. The vendor's substantial federal contract portfolio and established relationship with DLA demonstrate its capability to meet critical medical procurement requirements for the defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/12/25 |